Key facts
- This page summarizes Harry Kovelman's Form 4 filing for MYOMO, INC. (MYO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Jan 2025, 17:02.
Harry Kovelman - 09 Jun 2024 Form 4 Insider Report for MYOMO, INC. (MYO)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- MYO
- Reported as of
- 09 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Jan 2025, 17:02:01 UTC
- Prior SEC filing
- 07 Jun 2024
- Next SEC filing
- 12 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ David A. Henry, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Harry Kovelman filed Form 4 for MYOMO, INC. (MYO) on 24 Jan 2025.
Change
- Previous filing in this sequence was filed on 07 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MYO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,235
- Change %
- +1%
- Price
- $0.000000
- Shares after
- 124,549
- Date
- 09 Jun 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MYO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,235
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 09 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,235
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents vesting of performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive plan based on the relative stock price performance of the Company's common stock compared to a peer group of companies as measured from June 10, 2021 to March 9, 2024.
Footnote F2
Represents performance-based restricted stock units granted under the Issuer's 2018 Stock Option and Incentive Plan. 1,235 shares were earned based on the Company's relative stock price performance from June 10, 2021 to March 9, 2024 compared to a peer group of companies, which are reported in Table I of this report on Form 4. The remaining 6,965 restricted stock units granted expired unvested.